• Home
  • Study Details

Understanding Outcome Differences in Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL)

The purpose of this study is to understand why there are differences in outcomes in adolescents and young adults treated for Acute Lymphoblastic Leukemia.

Age & Gender

  • 15 years ~ 39 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Visits can be combined with regular clinical appointments


North Carolina (Statewide)

What will be asked of you

If you decide to take part in this study you will be asked to refill your regular doses of 6-mercaptopurine (6MP) and methotrexate (MTX) in a special MEMS® medication bottle with TrackCap™. This cap and bottle system will help the study team to track when the medication bottle is opened. You will be asked to fill out a questionnaire at the beginning and end of the study. A small amount of blood will be collected along with your regular blood draws.


In-person visits:
Total length of participation:
6 months

Looking for Specific Volunteers

Able to participate:

  • You have been diagnosed with ALL
  • You have Ph- precursor B-cell ALL or lymphoblastic lymphoma or T-cell ALL or Ph+ ALL.
  • You are receiving maintenance therapy with oral 6MP and MTX.
  • At the time of study enrollment, received less than 24 weeks of maintenance.
  • At the time of study enrollment, has less than 24 weeks remaining before end of maintenance.

Not eligible if:

  • You have Mature B-ALL (Burkitt leukemia).
  • Previously enrolled on a research study to measure or improve medication adherence.

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Andrew Smitherman

Study Type

Clinical or Medical

Study Topics

Cancer (Pediatric Cancers, Leukemia)
Child and Teen Health

IRB Number


Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research